GLP-1 medications like semaglutide and tirzepatide are not approved by the FDA for patients under age 18, with limited pediatric trial data
This is linked to many other comorbidities, he adds, including: Heart attack Stroke Chronic kidney disease (CKD) Non-alcoholic fatty liver disease (NAFLD) Sleep apnea (ongoing research) Fibrosis (ongoing research) The research is impressive
Frequency unknown: Angioedema, back pain, cutaneous vasculitis, interstitial lung disease, joint disorders, myalgia, pancreatitis, renal impairment, StevensJohnson syndrome, hepatic function abnormalities
Common Feedback Patients commonly report increased energy levels, reduced cravings, and overall improved wellbeing
You may also want to document any missed work due to your condition
However, it may take several days or even 1 to 2 weeks before Synjardy has its full effect on lowering your blood sugar level